AGIOS PHARMACEUTICALS, INC. Contract with Customer, Performance Obligation Satisfied in Previous Period
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Contract with Customer, Performance Obligation Satisfied in Previous Period of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Revenue from Contract with Customer
us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod · last filed 2021-02-25
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2020-12-31 was $0.00.
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2020-09-30 was $0.00.
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2020-06-30 was $0.00.
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2020 was $0.00.
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2018 was $469.00K.
- AGIOS PHARMACEUTICALS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2017 was $0.00.
| Period end | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 9 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-06-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | -$272.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | -$272.00K derived: sum of 3 quarters · filed 2021-02-25 | -$53.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $21.00K 10-Q · filed 2020-04-30 | -$272.00K derived: sum of 2 quarters · filed 2021-02-25 | -$53.00K derived: sum of 3 quarters · filed 2021-02-25 | $167.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$74.00K derived: sum of 2 quarters · filed 2021-02-25 | $146.00K derived: sum of 3 quarters · filed 2021-02-25 | $469.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $219.00K 10-Q · filed 2019-10-31 | $439.00K derived: sum of 2 quarters · filed 2019-10-31 | $762.00K 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $220.00K 10-Q · filed 2019-08-01 | $543.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $323.00K 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |